Form4insider filings, from the source

SEC Form 4 · accession 0001127602-15-019885

UNITED THERAPEUTICS Corp · UTHR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Martine A Rothblatt
Officer — Chairman & Co-CEO · Director
Period of report
Jun 4, 2015
Accepted (ET)
Jun 4, 2015 · 6:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Jun 4, 2015M5,547$30.75A5,787D
Common StockF3Jun 4, 2015S1,500$179.5095D4,287D
Common StockF4Jun 4, 2015S445$180.3946D3,842D
Common StockF5Jun 4, 2015S2,100$181.6411D1,742D
Common StockF6Jun 4, 2015S1,102$182.5873D640D
Common StockF7Jun 4, 2015S400$183.68D240D
Common StockF2Jun 4, 2015M4,115$34.56A4,355D
Common StockF8Jun 4, 2015S2,300$182.3955D2,055D
Common StockF9Jun 4, 2015S1,815$183.3112D240D
Common Stockholding———166IBy Spouse
Common Stockholding———625,031IBy Trusts

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock OptionsF2$30.75Jun 4, 2015M5,547DDec 26, 2009Dec 31, 2017Common Stock5,547454,819D
Stock OptionsF2$34.56Jun 4, 2015M4,115DDec 30, 2005Dec 30, 2015Common Stock4,11598,775D

Explanation of responses